Pharma & Biotech

MorphoSys Finalizes Delisting from Frankfurt and Nasdaq Markets Following Novartis Acquisition

(IN BRIEF) MorphoSys AG has completed its voluntary delisting from the Frankfurt Stock Exchange and Nasdaq Global Market following its…

1 year ago

EIB Invests €37.5 Million in Nyxoah’s Innovative Sleep Apnea Solutions

(IN BRIEF) The European Investment Bank (EIB) has awarded Belgium-based medtech company Nyxoah €37.5 million in venture-debt financing to support…

1 year ago

Roche Launches Advanced Diagnostic Test for B-Cell Lymphoma Detection

(IN BRIEF) Roche has introduced the VENTANA® Kappa and Lambda Dual ISH mRNA Probe Cocktail assay, the first clinically approved…

1 year ago

QIAGEN Launches Enhanced QCI Interpret for High-Throughput NGS Labs

(IN BRIEF) QIAGEN has launched an upgraded version of its clinical decision support software, QIAGEN Clinical Insight Interpret (QCI Interpret),…

1 year ago